ELMD Electromed, Inc.
XASE
26.87
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $23.01 – $47.40
- YTD
- -1.90%
- IV Rank (30D)
- 81.03
- Straddle Price
- $4.28
- P/C Vol Ratio
- 1.80
- Market Cap
- $0.2B
- Open
- $27.20
- Day Range
- $26.70 – $27.50
- Volume
- 32,692
- Prev Close
- $27.32
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 0.68 |
| Cost of Equity (CAPM) | 8.53% (VRP-adj) |
| WACC | 8.55% |
| Volatility Risk Premium | +102.4pp (IV − HV30) |
| Effective Tax Rate | 21.3% |
| Rev. Growth (YoY, DCF input) | +15.0% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 20.9% |
| Book / Price | 22.7% |
| Gross Margin (TTM) | 78.5% |
| FCF Margin (TTM) | 11.4% |
| Debt / Equity | 0.00 |
| Quality Score | 4/6 — high quality (12y DCF) |
| Market-Implied Growth | +8.9% (reverse-DCF on current price) |
| SMA 50 | $30.38 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $27.91 |
| Bollinger Width / SMA20 | 18.3% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $39.41 | 23% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $27.90 | 10% | median 19.4× · 8 peers |
| Peer EV/EBITDA | $21.88 | 10% | median 10.3× · 8 peers |
| Peer P/B | $21.50 | 2% | median 3.5× · 7 peers |
| Peer P/S | $18.07 | 7% | median 1.9× · 8 peers |
| Market Anchor (SMA50) | $30.38 | 31% | stability 67% (BB-width) |
| Options Expected (B-L 30d) | $28.04 | 16% | 14 strikes · skew +0.44 |

- Industry (SIC)
- ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS (3845) · industry map
- Exchange
- XASE
- Market Cap
- $0.2B
- Employees
- 197
- List Date
- 2010-08-13
- CIK
- 0001488917
- Next Earnings
- 2026-11-11 (After-Close)
- Headquarters
- New Prague, MN
- Homepage
- https://www.smartvest.com
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The …
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 1.33% | 0.39% | 5.89% | -6.60% | 14.29% | 9.05% | 4.06% |
| Feb | 3.94% | -4.74% | 18.34% | 50.94% | -20.19% | -21.45% | 4.47% |
| Mar | -6.39% | 1.55% | -21.45% | 5.21% | -8.86% | -2.86% | -5.47% |
| Apr | -11.10% | 1.77% | 6.52% | 7.21% | -4.80% | 8.71% | 1.39% |
| May | -1.89% | -9.48% | 12.30% | -17.17% | -12.36% | 47.34% | 3.12% |
| Jun | 10.79% | -15.40% | -9.01% | 2.87% | 7.48% | 15.48% | 2.04% |
| Jul | 3.44% | -8.89% | -4.32% | 10.53% | -16.47% | -7.95% | -3.94% |
| Aug | 8.56% | 7.30% | -2.27% | 11.87% | 36.40% | -32.73% | 4.86% |
| Sep | -17.66% | 10.81% | 3.49% | 24.46% | 2.51% | 4.17% | 4.63% |
| Oct | 2.52% | 3.71% | -4.19% | 11.24% | -2.00% | -5.72%* | 0.93% |
| Nov | 10.07% | -4.03% | -1.72% | 34.41% | 11.31% | -- | 10.01% |
| Dec | 7.53% | 6.39% | 4.50% | -1.83% | 6.20% | -- | 4.56% |
| Total | 6.89% | -13.18% | 2.02% | 206.07% | 0.87% | -6.40% | 32.71% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Here is my structured report:
Executive Summary
Overall Assessment: NEUTRAL (confidence level: 6/10)
Key drivers: Strong technical signals, low volatility, and positive earnings estimates.
Primary risks: Bearish MACD signal, oversold RSI, and potential breakdown risk at $22.10 support.
Investment thesis: ELMD is a neutral stock with potential for mean reversion and consolidation around its current price.
Recent news sentiment impact: Recent headlines have been mixed, but overall sentiment has been neutral.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Consolidation Medium-term (1-3 months): Uptrend Long-term (3-12 months): Neutral
Support/Resistance Levels: Key price levels: $22.10 (support), $27.07 (current price), and $34.64 (SMA 20)
Momentum Signals:
- RSI interpretation: Oversold (<30) at 22.21, potential buy signal.
- MACD signal: Bearish crossover, warning sign for a potential breakdown.
- Bollinger Bands position: Neutral squeeze.
Volume Analysis: Volume trends: Slightly declining volume since mid-July. Institutional interest signals: Low institutional activity, indicating potential accumulation or distribution.
News & Sentiment Analysis
Recent Headlines Summary:
- Negative (Benzinga)
- Positive (Zacks Investment Research) 3-6. Neutral (Zacks Investment Research)
Sentiment Assessment: Mixed sentiment with a slight negative bias due to the bearish MACD signal.
Catalyst Identification: Earnings expectations: No recent earnings data available, but options market is pricing in $3.80 move by expiration.
Market Narrative: News headlines have been mixed, but overall sentiment has been neutral. Technical signals indicate potential mean reversion and consolidation around the current price.
Risk & Volatility Assessment
Beta Interpretation: Beta 0.71 (low volatility) relative to SPY.
Volatility Regime: Historical volatility: Low to medium.
Options Market Signals: IV rank: Medium, indicating historically high volatility. Put/call ratio: Bullish sentiment at 0.07.
Downside Protection: Support levels: $22.10 and potential rebound risk around $27.07.
Market Context & Positioning
Sector Performance: ELMD is a healthcare stock with mixed sector performance recently.
Institutional Activity: Low institutional activity, indicating potential accumulation or distribution.
Correlation Analysis: R-squared interpretation: 0.17 (low correlation with the market), suggesting ELMD's price movements are relatively independent of the broader market.
Relative Valuation: Position within trading range: Neutral to slightly bullish due to the recent consolidation and mean reversion signals.
Key Levels & Action Items
Critical Price Levels: Support/resistance levels: $22.10, $27.07, and $34.64.
Breakout/Breakdown Levels: Technical levels that could trigger significant moves: $22.10 support and potential breakdown risk.
Time-Sensitive Catalysts: Earnings expectations: No recent earnings data available, but options market is pricing in $3.80 move by expiration.
Risk Management: Stop-loss levels and position sizing considerations: Monitor technical signals and adjust positions accordingly.
Please let me know if this meets your requirements!
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-09 | After-Close | 19.73% | 7.91% | 0.40x | Within |
| 2021-05-11 | After-Close | 11.94% | 7.86% | 0.66x | Within |
| 2023-05-09 | After-Close | 15.49% | 12.02% | 0.78x | Within |
| 2023-08-22 | After-Close | 19.01% | 10.59% | 0.56x | Within |
| 2023-11-07 | After-Close | 19.42% | 2.09% | 0.11x | Within |
| 2024-02-13 | After-Close | 10.16% | 26.92% | 2.65x | Exceeded |
| 2024-05-07 | After-Close | 15.48% | 2.46% | 0.16x | Within |
| 2024-08-27 | After-Close | 18.85% | 6.54% | 0.35x | Within |
| 2024-11-12 | Pre-Market | 18.72% | 1.49% | 0.08x | Within |
| 2025-02-11 | After-Close | 9.42% | 13.97% | 1.48x | Exceeded |
| 2025-05-13 | Pre-Market | 8.58% | 1.74% | 0.20x | Within |
| 2025-08-26 | After-Close | 12.22% | 19.89% | 1.63x | Exceeded |
| 2025-11-12 | After-Close | 7.58% | 3.82% | 0.50x | Within |
| 2026-02-10 | After-Close | 11.40% | 9.98% | 0.88x | Within |
| 2026-05-12 | After-Close | 12.41% | 25.11% | 2.02x | Exceeded |
| 2026-08-25 | After-Close | 14.43% | 19.24% | 1.33x | Exceeded |
Earnings calendar: this week’s reports with expected vs actual moves →
ELMD Options Activity & IV Rank
ELMD IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 77th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $4.2M | #1549 of 3138 | -19.6% | 13F | |
| Citadel Hedge fund Ken Griffin | $1.8M | #3056 of 6285 | +116.0% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $359K | #3294 of 3716 | -8.2% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ELMD Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $232.65K | 70.51% | 2026-06-30 |
| 2 | Simplex Trading, LLC Custodian | $97.29K | 29.49% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | GROUP ONE TRADING LLC Custodian | $4.23K | 100.00% | 2026-06-30 |
ELMD Insider Trading (Form 4)
Latest: 2026-09-03| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | James L. Cunniff | CEO and President | Tax (F) | −2,671 | $27.10 | -$72.4K | EDGAR |
| 2026-09-03 | Bradley M. Nagel | Chief Financial Officer | Mixed | +3,798 | $27.10 | -$29.9K | EDGAR |
| 2026-07-02 | Bradley M. Nagel | Chief Financial Officer | Tax (F) | −674 | $42.30 | -$28.5K | EDGAR |
| 2026-06-09 | James L. Cunniff | CEO and President | Mixed | — | $26.88 | -$186.8K | EDGAR |
| 2026-06-08 | Bradley M. Nagel | Chief Financial Officer | Mixed | −2,200 | $24.75 | -$328.1K | EDGAR |
| 2026-05-19 | Kathleen Skarvan | Director | Mixed | — | $19.65 | -$1.27M | EDGAR |
| 2025-12-03 | Andrea M. Walsh | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-12-03 | Stan K. Erickson | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-12-03 | Gregory Fluet | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-12-03 | Joseph L. Galatowitsch | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-12-03 | Andrew Summers | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-12-03 | Kathleen A Tune | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-12-03 | Kathleen Skarvan | Director | Award (A) | +3,000 | — | EDGAR | |
| 2025-09-12 | Andrew Summers | Director | Sell (S) | −65,714 | $24.32 | -$1.60M | EDGAR |
| 2025-09-04 | Bradley M. Nagel | Chief Financial Officer | Mixed | +4,738 | $23.95 | -$13.5K | EDGAR |
ELMD Insider Holdings
9 insiders · @ $26.84| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Andrew Summers | Director | 282,367 | $7.58M | -$7.45M | 9 | 2025-12-03 |
| 2 | James L. Cunniff | CEO and President | 145,080 | $3.89M | -$206.3K | 9 | 2026-09-03 |
| 3 | Kathleen Skarvan | Director | 44,184 | $1.19M | -$7.82M | 29 | 2026-05-19 |
| 4 | Stan K. Erickson | Director | 40,317 | $1.08M | $15.6K | 13 | 2025-12-03 |
| 5 | Bradley M. Nagel | Chief Financial Officer | 23,864 | $640.6K | -$428.9K | 8 | 2026-09-03 |
| 6 | Gregory Fluet | Director | 21,000 | $563.7K | $0 | 7 | 2025-12-03 |
| 7 | Andrea M. Walsh | Director | 18,000 | $483.2K | $0 | 6 | 2025-12-03 |
| 8 | Kathleen A Tune | Director | 15,000 | $402.7K | $0 | 5 | 2025-12-03 |
| 9 | Joseph L. Galatowitsch | Director | 15,000 | $402.7K | $0 | 5 | 2025-12-03 |
ELMD Board & Officers
As of SEC filings through Sep 3, 2026Directors 8
- Kathleen Skarvan · listed since Jul 2014
- Stan K. Erickson · since Nov 21, 2014
- Gregory Fluet · since Aug 13, 2019
- Andrea M. Walsh · since Nov 13, 2020
- Joseph L. Galatowitsch · since Nov 12, 2021
- Kathleen A Tune · since Nov 12, 2021
- Andrew Summers · since Jul 25, 2022
- James L. Cunniff · since Jul 1, 2023
Officers 2
- James L. Cunniff · CEO and President · since Jul 1, 2023
- Bradley M. Nagel · Chief Financial Officer · since Nov 14, 2022
Changes in the last 10 years (16)
| Jul 1, 2023 | James L. Cunniff became a director |
| Jul 1, 2023 | James L. Cunniff became CEO and President |
| Jun 13, 2023 | The company announced the departure of Christopher G. Holland as Chief Commercial Officer in an SEC filing |
| Feb 14, 2023 | The company announced the departure of Kathleen Skarvan as President and CEO in an SEC filing |
| Nov 14, 2022 | Bradley M. Nagel became Chief Financial Officer |
| Oct 19, 2022 | The company announced the departure of Michelle C. Wirtz as Chief Financial Officer in an SEC filing |
| Jul 25, 2022 | Andrew Summers became a director |
| Jun 1, 2022 | Michelle C. Wirtz became Chief Financial Officer |
| May 6, 2022 | The company announced the departure of Michael Joseph Maccourt as Chief Financial Officer in an SEC filing |
| Feb 16, 2022 | Christopher G. Holland became Chief Commercial Officer |
| Nov 12, 2021 | Kathleen A Tune became a director |
| Nov 12, 2021 | Joseph L. Galatowitsch became a director |
| Nov 13, 2020 | Andrea M. Walsh became a director |
| May 26, 2020 | Michael Joseph Maccourt became Chief Financial Officer |
| Aug 13, 2019 | John L Erb became a director |
| Aug 13, 2019 | Gregory Fluet became a director |
Not reported recently (7)
- A Jones Lee · Last reported as a director in an SEC filing dated Dec 5, 2022
- Stephen H. Craney · Last reported as a director in an SEC filing dated May 19, 2021
- George H. Winn · Last reported as a director in an SEC filing dated Dec 3, 2020
- Jeremy T. Brock · Last reported as Chief Financial Officer in an SEC filing dated May 26, 2020
- John L Erb · Last reported as a director in an SEC filing dated Dec 4, 2019
- William V. Eckles · Last reported as a director in an SEC filing dated Dec 4, 2018
- Red Oak Partners, LLC · Last reported as a 10% owner in an SEC filing dated Oct 4, 2017
ELMD Proposed Insider Sales (Form 144)
Latest: 2026-06-08What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | Cunniff James L. | Officer, Director | 9,700 | $354.1K | 2026-06-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-04 | Nagel Bradley M. | Officer | 11,801 | $428.9K | 2026-06-04 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-05-15 | SKARVAN KATHLEEN | Director | 40,000 | $1.42M | 2026-05-15 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-09-10 | SVP DEAL FUND 1 LP | Affiliate | 65,714 | $1.55M | 2025-09-10 | BTIG, LLC | — | EDGAR |
| 2025-02-20 | Summers Value Fund LP | Affiliate | 50,000 | $1.43M | 2025-02-20 | BTIG, LLC | — | EDGAR |
| 2025-02-20 | SVP DEAL FUND 1 LP | Affiliate | 146,827 | $4.20M | 2025-02-20 | BTIG, LLC | — | EDGAR |
| 2025-02-18 144/A | SKARVAN KATHLEEN | Director | 100,000 | $3.20M | 2025-02-14 | LPL Financial | — | EDGAR |
| 2024-12-02 | Summers Value Fund LP | Affiliate | 75,000 | $2.26M | 2024-12-02 | BTIG, LLC | — | EDGAR |
| 2024-12-02 | SVP DEAL FUND 1 LP | Affiliate | 75,000 | $2.26M | 2024-12-02 | BTIG, LLC | — | EDGAR |
| 2024-11-18 | SKARVAN KATHLEEN | Director | 150,000 | $4.33M | 2024-11-18 | LPL Financial | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $5.6M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $4.6M | $75.1B | 2026-10-20 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $2.3M | — | 2026-09-30 |
| 4 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.01% | $2.0M | — | 2026-10-20 |
| 5 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.01% | $1.7M | $13.6B | 2026-10-20 |
| 6 | FSMD Fidelity Small-Mid Multifactor ETF | Fidelity | 0.06% | $1.4M | $2.5B | 2026-10-20 |
| 7 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $1.2M | — | 2026-09-30 |
| 8 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.01% | $817,108 | — | 2026-10-20 |
| 9 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.05% | $585,460 | $1.2B | 2026-10-20 |
| 10 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $566,801 | — | 2026-10-20 |
| 11 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.01% | $360,973 | $3.1B | 2026-10-20 |
| 12 | FESM Fidelity Enhanced Small Cap Core ETF | Fidelity | 0.00% | $322,530 | $6.6B | 2026-10-20 |
| 13 | GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | Goldman | 0.03% | $291,660 | $1.0B | 2026-10-20 |
| 14 | ROSC Hartford Multifactor Small Cap ETF | Nport | 0.44% | $269,022 | — | 2026-07-31 |
| 15 | DUSG Dimensional US Small Cap Growth ETF | Dimensional | 0.01% | $268,885 | — | 2026-10-20 |
| 16 | VFMF Vanguard U.S. Multifactor ETF | Vanguard | 0.02% | $233,652 | — | 2026-10-20 |
| 17 | EES WisdomTree U.S. SmallCap Fund | Nport | 0.03% | $226,474 | — | 2026-06-30 |
| 18 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.01% | $211,979 | — | 2026-09-30 |
| 19 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $169,662 | — | 2026-10-20 |
| 20 | VFQY Vanguard U.S. Quality Factor ETF | Vanguard | 0.03% | $149,274 | — | 2026-10-20 |
| 21 | DXUV Dimensional US Vector Equity ETF | Dimensional | 0.00% | $118,541 | — | 2026-10-20 |
| 22 | OMFS Invesco Russell 2000 Dynamic Multifactor ETF | Nport | 0.03% | $96,940 | — | 2026-05-31 |
| 23 | FSML Franklin Small Cap Enhanced ETF | Franklin | 0.06% | $94,147 | $151.3M | 2026-10-20 |
| 24 | RSSL Global X Russell 2000 ETF | Global X | 0.01% | $88,626 | — | 2026-10-21 |
| 25 | AVUS Avantis U.S. Equity ETF | Avantis | 0.00% | $52,109 | $14.8B | 2026-10-20 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q4 '26 | 2026-06-30 | $19.42M | $3.40M | $0.39 | $2.99M |
| Q3 '26 | 2026-03-31 | $18.57M | $3.00M | $0.35 | $3.48M |
| Q2 '26 | 2025-12-31 | $18.90M | $2.76M | $0.32 | $3.03M |
| Q1 '26 | 2025-09-30 | $16.89M | $2.14M | $0.25 | $169.00K |
| Q4 '25 | 2025-06-30 | $17.39M | $2.20M | $0.25 | $3.86M |
| Q3 '25 | 2025-03-31 | $15.68M | $1.89M | $0.21 | $2.07M |
| Q2 '25 | 2024-12-31 | $16.25M | $1.97M | $0.22 | $3.15M |
| Q1 '25 | 2024-09-30 | $14.67M | $1.47M | $0.16 | $2.31M |
| Q4 '24 | 2024-06-30 | $14.83M | $1.83M | $0.20 | $4.49M |
| Q3 '24 | 2024-03-31 | $13.87M | $1.49M | $0.17 | $1.35M |
| Q2 '24 | 2023-12-31 | $13.69M | $1.67M | $0.19 | $3.47M |
| Q1 '24 | 2023-09-30 | $12.32M | $155.00K | $0.02 | $-244.00K |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.